We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+24.71%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$866M
AUM Growth
+$149M
(+21%)
Cap. Flow
+$43.9M
Cap. Flow
% of AUM
5.07%
Top 10 Holdings %
Top 10 Hldgs %
7.14%
Holding
453
New
147
Increased
91
Reduced
74
Closed
130
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CSII
Cardiovascular Systems, Inc.
CSII
|
+$4.71M |
| 2 |
GIMO
Gigamon Inc.
GIMO
|
+$4.45M |
| 3 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
+$4.39M |
| 4 |
SAAS
inContact, Inc.
SAAS
|
+$4.38M |
| 5 |
INN
Summit Hotel Properties
INN
|
+$4.32M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESPR
Esperion Therapeutics
ESPR
|
+$6.11M |
| 2 |
IMPV
Imperva, Inc.
IMPV
|
+$5.46M |
| 3 |
RadNet
RDNT
|
+$5.41M |
| 4 |
PLNR
PLANAR SYSTEMS INC
PLNR
|
+$4.97M |
| 5 |
Motorcar Parts of America
MPAA
|
+$4.78M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.59% |
| 2 | Technology | 18.66% |
| 3 | Consumer Discretionary | 13.65% |
| 4 | Industrials | 11.89% |
| 5 | Communication Services | 5.43% |
Similar funds
RWM
MCM
HP
OMG
ICCFIA
WFAL
WCM
TSS
EAM Investors's Q1 2015 Portfolio in Review
As of Q1 2015, EAM Investors held 453 positions worth $866M, up 21% from $717M the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
EAM Investors deployed $43.9M of net new capital in Q1 2015, opening 147 new positions and adding to 91 existing holdings. Its largest new stake was Cardiovascular Systems, Inc.: 136,844 shares worth $5.34M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 27% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Esperion Therapeutics, an estimated $6.11M trimmed.
- EAM Investors's largest Q1 2015 buy was Cardiovascular Systems, Inc.: 136,844 shares worth $5.34M.
- EAM Investors added most to NEVRO CORP. in Q1 2015, an estimated $3.15M increase.
- EAM Investors's biggest Q1 2015 reduction was Esperion Therapeutics, cutting an estimated $6.11M.
- EAM Investors fully exited Imperva, Inc. in Q1 2015, selling an estimated $5.46M.
- EAM Investors's ten largest holdings make up 7.1% of its $866M portfolio in Q1 2015.
- EAM Investors opened 147 new positions and closed 130 in Q1 2015.
- EAM Investors's portfolio value rose 21% quarter-over-quarter to $866M.
Based on EAM Investors's 13F filing for Q1 2015, filed 7 May 2015.